Form 4: INSMED Director Melvin Sharoky Reports Share Sales, Gifts

INSMED Director Melvin Sharoky, MD, reported the sale of 10,000 common shares for $145.39 each and several gift transactions under a 10b5-1 plan.

Summary

• Melvin Sharoky, MD, a Director of INSMED Inc. (INSM), reported changes in beneficial ownership of common stock.
• On September 11, 2025, Dr. Sharoky gifted 2,000 shares of common stock from his direct holdings.
• Also on September 11, 2025, 159 shares were gifted from Baby Gator LLC, an entity where Dr. Sharoky is a managing member, and simultaneously 159 shares were acquired into his direct holdings as a gift, both at a price of $0.
• On September 12, 2025, Dr. Sharoky sold 10,000 shares of common stock from his direct holdings at a weighted average price of $145.39 per share.
• The sale transaction was executed pursuant to a Rule 10b5-1 trading plan, indicating a pre-scheduled disposition.
• Following these transactions, Dr. Sharoky directly holds 262,675 shares and maintains significant indirect holdings through various entities and accounts.

Sentiment

Score: 5

Explanation: The sentiment is neutral to slightly negative. While a director's sale of shares can be perceived negatively, the existence of a 10b5-1 plan mitigates immediate concerns about insider sentiment. The gifts also represent a reduction in beneficial ownership. The overall impact is relatively neutral given the pre-planned nature of the sale and the director's remaining significant holdings.

Positives

• The sale of 10,000 shares was conducted under a Rule 10b5-1(c) plan, indicating a pre-scheduled transaction rather than a discretionary sale based on immediate market conditions.
• Dr. Sharoky retains substantial direct and indirect beneficial ownership in INSMED Inc., demonstrating continued alignment with shareholder interests.

Negatives

• Dr. Sharoky disposed of a total of 12,159 shares (2,000 gifted directly, 159 gifted indirectly, and 10,000 sold directly), representing a reduction in his overall beneficial ownership.
• The sale of 10,000 shares at $145.39 per share represents a disposition of value from the director's direct holdings.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Gift of 159 shares from Baby Gator LLC, an entity where Dr. Sharoky is a managing member.
• Indirect beneficial ownership through Baby Gator LLC and Padonia, LLC, both managed by Dr. Sharoky.
• Indirect beneficial ownership through spouse and various Uniform Transfers to Minors Act (UTMA) accounts for which Dr. Sharoky is custodian.

Stakeholder Impact

• Shareholders: The sale of shares by a director, even under a 10b5-1 plan, might be viewed with slight caution, though the pre-planned nature reduces the implication of negative insider sentiment. The gifts also reduce the total shares beneficially owned by the director.

Key Dates

Recommendation

The filing details routine insider transactions, including a pre-planned sale under a 10b5-1 plan and gift transfers. While a director selling shares can sometimes signal a lack of confidence, the pre-scheduled nature of the sale mitigates this concern. The director retains significant direct and indirect holdings. Without additional information on company performance or strategic shifts, these transactions alone do not warrant a change in investment thesis, suggesting a 'hold' recommendation.

Keywords

INSMED Inc, INSM, Melvin Sharoky, Director, Insider Trading, Form 4, Share Sale, Stock Gift, Beneficial Ownership, 10b5-1 Plan, Common Stock